Comparison of B-cell Depletion and Natalizumab for Treatment of Multiple Sclerosis: A Semi-supervised Causal Analysis (P8-1.008)
{{output}}
Objective: We compared BCD and NTZ in managing MS patient-reported disability progression using registry-linked electronic healthcare record (EHR) data. Backgroun... ...
